View Cart (0 items)
Pharmaceutical

Sanofi Launches Hostile Bid for Genzyme

October 04, 2010
/ Print / Reprints /
| Share More
/ Text Size+

Sanofi-Aventis said that it has launched a hostile $18.5 billion offer for Genzyme Corp. after the U.S. company previously rejected an approach at the same price, reports MarketWatch. The offer is worth $69 a share in cash, representing a 31-percent premium to the average price over the month before speculation began that it had approached Genzyme. Sanofi-Aventis added that it has met with shareholders holding more than 50-percent of Genzyme. The offer is scheduled to expire on Dec. 10.

You must login or register in order to post a comment.